Drug search by name

Ferriprox and Agranulocytosis/neutropenia

Result of checking the interaction of drug Ferriprox and disease Agranulocytosis/neutropenia for safety when used together.

Check result:

Ferriprox <> Agranulocytosis/neutropenia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Fatal agranulocytosis and neutropenia can occur with the use of deferiprone. It is recommended to obtain an absolute neutrophil count before initiating treatment with deferiprone and monitor weekly thereafter or as clinically appropriate. Manage agranulocytosis/neutropenia prior to initiating treatment. Therapy should be interrupted if neutropenia develops or if an infection develops. Do not resume therapy in patients who have developed agranulocytosis and do not rechallenge patients who develop neutropenia unless potential benefits outweigh potential risks.

Ferriprox

Generic Name: deferiprone

Brand Name: Ferriprox

Synonyms: n.a.

What is Ferriprox?